News

Congenital Hyperinsulinism International Issues Statement of Support for New Recommendations


 

References

Congenital Hyperinsulinism International (CHI) has issued a statement encouraging widespread adoption of recommendations published recently by the Pediatric Endocrine Society regarding evaluation and management of persistent hypoglycemia in neonates, infants, and children. In a survey conducted by CHI, 60% of the infants with congenital hyperinsulinism were not diagnosed during the newborn period. Failure to identify this condition can lead to brain damage or death. To read more: https://www.pedsendo.org/education_training/healthcare_providers/consensus_statements/assets/PES_recommendation_hypoglycemia.pdf

Recommended Reading

Congenital Hyperinsulinism International Issues Statement of Support for New Recommendations
MDedge Family Medicine
Progeria Research Foundation is Accepting Applications for Grants
MDedge Family Medicine
World Federation of Hemophilia Seeks Proposals
MDedge Family Medicine
NORD Announces Rare Disease Research Funding Opportunities
MDedge Family Medicine
NORD and SLS Community Launch Registry for Patients and Researchers
MDedge Family Medicine
200 Patient Organizations Join NORD in Letter to Energy and Commerce Committee
MDedge Family Medicine
White Paper Affirms Value of Orphan Drug Tax Credit in Promoting R&D
MDedge Family Medicine
Pediatric Family History to Be Subject of Webinar
MDedge Family Medicine
NIH NCATS Researchers Partner with Patient Organizations
MDedge Family Medicine
Funding Opportunities From the Vasculitis Foundation
MDedge Family Medicine